share_log
Moomoo 24/7 ·  Apr 24 16:49
Acrivon Therapeutics Shares Are Trading Higher After the Company Reported Initial Clinical Data for ACR-368 and Pipeline Program Progress Today at a Corporate R&D Event
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment